LEADER 04515nam 2200673 a 450 001 9910827768503321 005 20240416223719.0 010 $a1-281-24041-9 010 $a9786611240417 010 $a1-84787-675-7 035 $a(CKB)1000000000410597 035 $a(EBL)334563 035 $a(OCoLC)476143658 035 $a(SSID)ssj0000097711 035 $a(PQKBManifestationID)11120212 035 $a(PQKBTitleCode)TC0000097711 035 $a(PQKBWorkID)10137629 035 $a(PQKB)10119949 035 $a(MiAaPQ)EBC334563 035 $a(OCoLC)648355247 035 $a(StDuBDS)EDZ0000062098 035 $a(Au-PeEL)EBL334563 035 $a(CaPaEBR)ebr10218053 035 $a(CaONFJC)MIL124041 035 $a(EXLCZ)991000000000410597 100 $a20120307d2001 fy| 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt 182 $cc 183 $acr 200 04$aThe advanced handbook of methods in evidence based healthcare /$fedited by Andrew Stevens ... [et al.] 205 $a1st ed. 210 $aThousand Oaks, Calif. ;$aLondon $cSAGE$dc2001 215 $a1 online resource (xxx, 507 p.) $cill 300 $aDescription based upon print version of record. 311 $a1-84860-834-9 311 $a0-7619-6144-5 320 $aIncludes bibliographical references and index. 327 $aCover; Contents; Contributors; INTRODUCTION Methods in Evidence Based Healthcare and Health Technology Assessment: An Overview; Part I CLINICAL TRIALS; 1 Ethical Issues in the Design and Conduct of Randomised Controlled Trials; 2 Ethics of Clinical Trials: Social, Cultural and Economic Factors; 3 Factors that Limit the Number, Progress and Quality of Randomised Controlled Trials: A Systematic Review; 4 Results of Clinical Trials and Systematic Reviews: To Whom Do They Apply?; 5 The Placebo Effect: Methodological Process and Implications of a Structured Review 327 $aPart II OBSERVATIONAL AND QUALITATIVE METHODS6 Randomised and Non-Randomised Studies: Threats to Internal and External Validity; 7 A Review of Observational, Quasi-Experimental and Randomised Study Designs for the Evaluation of the Effectiveness of Healthcare Interventions; 8 The Potential Use of Routine Datasets in Health Technology Assessment; 9 Using Routine Data to Complement and Enhance the Results of Randomised Controlled Trials; 10 Qualitative Methods in Health Technology Assessment; Part III MEASUREMENT OF BENEFIT AND COST 327 $a11 Criteria for Assessing Patient Based Outcome Measures for Use in Clinical Trials12 The Use of Health Status Measures in Economic Evaluation; 13 Collecting Resource Use Data for Costing in Clinical Trials; 14 Eliciting Time Preferences for Health; 15 The Conduct and Design of Questionnaire Surveys in Healthcare Research; Part IV ANALYTICAL METHODS; 16 Bayesian Methods; 17 Methods for Evaluating Organisation- or Area-Based Health Interventions; 18 Handling Uncertainty in Economic Evaluation 327 $a19 A Review of the Use of the Main Quality of Life Measures, and Sample Size Determination for Quality of Life Measures, Particularly in Cancer Clinical Trials20 Simultaneous Analysis of Quality of Life and Survival Data; Part V CONSENSUS, REVIEWS AND META-ANALYSIS; 21 Publication and Related Biases; 22 Meta-Analysis in Health Technology Assessment; 23 Assessing the Quality of Reports of Randomised Trials Included in Meta-Analyses: Attitudes, Practice, Evidence and Guides; 24 Consensus Development Methods, and their Use in Creating Clinical Guidelines 327 $aPart VI IDENTIFYING AND FILLING GAPS IN THE EVIDENCE25 Identifying New Healthcare Technologies; 26 Timing of Assessment of Fast-Changing Health Technologies; 27 Preliminary Economic Evaluation of Health Technologies; Index 330 8 $aThis text provides a comprehensive, state-of-the-art review of the available methods of health care evaluation. 606 $aMedical care$zGreat Britain$xEvaluation 606 $aMedical care$zGreat Britain$xEvaluation 606 $aEvidence-based medicine$zGreat Britain$xEvaluation 615 0$aMedical care$xEvaluation. 615 0$aMedical care$xEvaluation. 615 0$aEvidence-based medicine$xEvaluation. 676 $a362.10941 701 $aStevens$b Andrew$cDr.$01018428 801 0$bStDuBDS 801 1$bStDuBDS 906 $aBOOK 912 $a9910827768503321 996 $aThe advanced handbook of methods in evidence based healthcare$94112221 997 $aUNINA